Peroxisome proliferator activated receptor (PPAR)-gamma concentrations in childhood obesity

References

• ILSI European Overweight and Obesity in Children Task Force. Overweight and obesity in European children and adolescents: causes and consequences- prevention and treatment. The International Live Science Institute. Europe Report Series 2000:4–22.
   Google Scholar
• Alemzadeh R, Lifshitz F. Childhood obesity. In: Lifshitz F, editor. Pediatric endocrinology, 4th ed. New York: Marcel Dekker; 2003. pp 823–58.
   Google Scholar
• Caprio S, Tamborlane WV. Metabolic impact of obesity in childhood. Endocrinol Metab Clin North Am 1999;28: 731–47.
   PubMed Web of Science ®Google Scholar
• Omi T, Brenig B, Spilar KS, Iwamoto S, Stranzinger G, Neuenschwander S. Identification and characterization of novel peroxisome proliferator-activated receptor- gamma (PPAR-gamma) transcriptional variants in pig and human. J Anim Breed Genet 2005;122(Suppl. 1): 45–53.
   PubMed Web of Science ®Google Scholar
• Dubois M, Pattou F, Kerr-Conte J, Gmyr V, Vandewalle B, Desreumaux P, Auwerx J, Schoonjans K, Lefebvre J. Expression of peroxisome proliferatoractivated receptor gamma (PPARgamma) in normal human pancreatic islet cells. Diabetologia 2000;43:1165–9.
   PubMed Web of Science ®Google Scholar
• Yamauchi T, Kamon J, Waki H, Murakami K, Motojima K, Komeda K, Ide T, Kubota N, Terauchi Y, Tobe K, Miki H, Tsuchida A, Akanuma Y, Nagai R, Kimura S, Kadowaki T. The mechanisms by which both heterozygous peroxisome proliferator-activated receptor gamma (PPARgamma) deficiency and PPARgamma agonist improve insulin resistance. J Biol Chem 2001;276:41245–54.
   PubMed Web of Science ®Google Scholar
• Cheng L, Ding G, Qin Q, Huang Y, Lewis W, He N, Evans RM, Schneider MD, Brako FA, Xiao Y, Chen YE, Yang Q. Cardiomyocyte-restricted peroxisome proliferator-activated receptor-delta deletion perturbs myocardial fatty acid oxidation and leads to cardiomyopathy. Nat Med 2004; 10:1245–50.
   PubMed Web of Science ®Google Scholar
• Bundak R, Furman A, Gunoz H, Darendeliler F, Bas F, Neyzi O. Body mass index references for Turkish children. Acta Paediatr 2006;95:194–8.
   PubMed Web of Science ®Google Scholar
• Hatipoglu N, Ozturk A, Mazicioglu MM, Kurtoglu S, Seyhan S, Lokoglu F. Waist circumference percentiles for 7- to 17-year-old Turkish children and adolescents. Eur J Pediatr 2008;167:383–9.
   PubMed Web of Science ®Google Scholar
• Tümer N, Yalçinkaya F, Ince E, Ekim M, Köse K, Cakar N, Kara N, Ozkaya N, Ensari C, Onder S. Blood pressure nomograms for children and adolescents in Turkey. Pediatr Nephrol 1999;13:438–43.
   PubMed Web of Science ®Google Scholar
• Zimmet P, Alberti G, Kaufman F, Tajima N, Silink M, Arslanian S, Wong G, Bennett P, Shaw J, Caprio S. International Diabetes Federation Task Force on epidemiology and prevention of diabetes. The metabolicsyndrome in children and adolescents. Lancet 2007;369:2059–61.
   PubMed Web of Science ®Google Scholar
• Keskin M, Kurtoglu S, Kendirci M, Atabek ME, Yazici C. Homeostasis model assessment is more reliable than the fasting glucose/insulin ratio and quantitative insulin sensitivity check index for assessing insulin resistance among obese children and adolescents. Pediatrics 2005;115:500–3.
   PubMed Web of Science ®Google Scholar
• Tanner JM. Growth at adolescence, 2nd ed. Oxford, UK: Blackwell Scientific Publications; 1962.
   Google Scholar
• PPAR α & γ. Complete Transcription Factor Assay Kit Catalog no.: 10008878 Cayman Chemical Company, Ann Arbor, USA 2006.
   Google Scholar
• Zimmet P, Alberti KG, Kaufman F, Tajima N, Silink M, Arslanian S, Wong G, Bennett P, Shaw J, Caprio S. IDF Consensus Group. The metabolic syndrome in children and adolescents – an IDF consensus report. Pediatr Diabetes 2007;8:299–306.
   PubMed Web of Science ®Google Scholar
• Cook S, Auinger P, Li C, Ford ES. Metabolic syndrome rates in United States adolescents, from the National Health and Nutrition Examination Survey, 1999–2002. J Pediatr 2008;152:165–70.
   PubMed Web of Science ®Google Scholar
• Moller DE, Berger JP. Role of PPARs in the regulation of obesity-related insulin sensitivity and inflammation. Int J Obes Relat Metab Disord 2003;27(Suppl. 3):S17–21.
   PubMed Web of Science ®Google Scholar
• Picard F, Auwerx J. PPAR(gamma) and glucose homeostasis. Annu Rev Nutr 2002;22:167–97.
   PubMed Web of Science ®Google Scholar
• Lagou V, Scott RA, Manios Y, Chen TL, Wang G, Grammatikaki E, Kortsalioudaki C, Liarigkovinos T, Moschonis G, Roma-Giannikou E, Pitsiladis YP. Impact of peroxisome proliferator-activated receptors gamma and delta on adiposity in toddlers and preschoolers in the GENESIS Study. Obesity (Silver Spring) 2008;16:913–8.
   PubMed Web of Science ®Google Scholar
• Li X, Lindquist S, Angsten G, Yi J, Olsson T, Hernell O. Adiponectin and peroxisome proliferator-activated receptor gamma expression in subcutaneous and omental adipose tissue in children. Acta Paediatr 2008;97:630–5.
   PubMed Web of Science ®Google Scholar
• Johansson LE, Danielsson P, Norgren S, Marcus C, Ridderstråle M. Interaction between PPARG Pro12Ala and ADIPOQ G276T concerning cholesterol levels in childhood obesity. Int J Pediatr Obes 2009;4:119–25.
   PubMed Web of Science ®Google Scholar
• Han GP, Ren JY, Qin L, Song JX, Wang L, Chen H. High density lipoprotein suppresses lipoprotein associated phospholipase A2 in human monocytes-derived macrophages through peroxisome proliferator-activated receptor-γ pathway. Chin Med J (Engl) 2012;125(24):4474–80.
   PubMed Web of Science ®Google Scholar
• Chinetti G, Lestavel S, Bocher V, Remaley AT, Neve B, Torra IP, Teissier E, Minnich A, Jaye M, Duverger N, Brewer HB, Fruchart JC, Clavey V, Staels B. PPAR-alpha and PPARgamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat Med 2001;7:53–8.
   PubMed Web of Science ®Google Scholar
• Schupp M, Janke J, Clasen R, Unger T, Kintscher U. Angiotensin type 1 receptor blockers induce peroxisome proliferator-activated receptor-g activity. Circulation 2004; 109:2054–7.
   PubMed Web of Science ®Google Scholar
• Pershadsingh HA, Kurtz TW. Insulin-sensitizing effects of telmisartan: implications for treating insulin-resistant hypertension and cardiovascular disease. Diabetes Care 2004;27:1015.
   PubMed Web of Science ®Google Scholar